Silence Therapeutics SLN

NASDAQ SLN

$14.69 -0.10 (-0.71%)

As of: Sep 4, 2026 · 1:39 PM EDT

Silence Therapeutics (SLN) Property, Plant & Equipment (Net) Growth (5y) (2023 - 2025)

Analysis

Silence Therapeutics (SLN) Property, Plant & Equipment (Net) Growth (5y) (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.26 Bn	131.41 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.64 Bn	77.64 Bn	3.93 Bn
3	Argenx Se	63.46 Bn	58.27 Bn	1.37 Bn
4	Moderna	57.83 Bn	52.69 Bn	52.00 Mn
5	Revolution Medicines	44.08 Bn	44.08 Bn	-
6	BeOne Medicines	39.94 Bn	34.84 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.19 Bn	31.88 Bn	992.69 Mn
8	Royalty Pharma	28.42 Bn	27.58 Bn	-
9	Insmed	27.35 Bn	26.19 Bn	358.27 Mn
10	Silence Therapeutics	693.67 Mn	621.57 Mn	-

Historic Data

Historic Data

Download Data

Date	Value
Dec 31, 2025	-34.02%
Dec 31, 2024	-30.33%
Dec 31, 2023	5.64%

Silence Therapeutics

NASDAQ: SLN

$14.69 ▼ -0.10 (-0.71%)

Sep 4, 2026 · 1:39 PM EDT